Santa Cruz Biotechnology delivers a wide array of ZNF181 monoclonal antibodies for various research applications. ZNF181 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ZNF181, a member of the zinc finger protein family, plays a crucial role in transcriptional regulation and is involved in various cellular processes, including differentiation and development. The significance of ZNF181 in gene expression regulation makes it a key target for studies related to cancer and other diseases. Understanding ZNF181 function can provide insights into the molecular mechanisms underlying these conditions. Research focused on ZNF181 continues to reveal new aspects of cellular regulation and disease progression. Investigating ZNF181 expression patterns helps scientists better understand its role in normal development and pathological conditions. The molecular characterization of ZNF181 advances knowledge about transcriptional control mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of ZNF181's role in health and disease.